PDS BIOTECHNOLOGY CORPORATION - COMMON STOCK
3.2010
01-November-24 15:59:58
15 minutes delayed
Stocks
+0.0110
+0.34%
Today's range
3.1500 - 3.3500
ISIN
N/A
Source
NASDAQ
-
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
27 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
20 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 16:45:19 By Nasdaq GlobeNewswire
-
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
16 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 Dec 2023 16:50:00 By Nasdaq GlobeNewswire
-
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
28 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
14 Nov 2023 07:30:55 By Nasdaq GlobeNewswire
-
PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results
07 Nov 2023 08:00:01 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
02 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
PDS Biotech to Present at the LD Micro Main Event XVI
26 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
25 Sep 2023 08:00:13 By Nasdaq GlobeNewswire
-
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
20 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
20 Sep 2023 08:00:18 By Nasdaq GlobeNewswire
-
PDS Biotech to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
06 Sep 2023 16:05:00 By Nasdaq GlobeNewswire